BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16813840)

  • 1. Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era.
    Pedersen SS; Ong AT; Lemos PA; Erdman RA; Serruys PW; van Domburg RT
    J Psychosom Res; 2006 Jul; 61(1):11-7. PubMed ID: 16813840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era.
    Spindler H; Pedersen SS; Serruys PW; Erdman RA; van Domburg RT
    J Affect Disord; 2007 Apr; 99(1-3):173-9. PubMed ID: 17049996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired health status in Type D patients following PCI in the drug-eluting stent era.
    Pedersen SS; Denollet J; Ong AT; Serruys PW; Erdman RA; van Domburg RT
    Int J Cardiol; 2007 Jan; 114(3):358-65. PubMed ID: 16753232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention.
    Pedersen SS; Denollet J; Spindler H; Ong AT; Serruys PW; Erdman RA; van Domburg RT
    J Psychosom Res; 2006 Dec; 61(6):783-9. PubMed ID: 17141666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.
    Spertus JA; Nerella R; Kettlekamp R; House J; Marso S; Borkon AM; Rumsfeld JS
    Circulation; 2005 Feb; 111(6):768-73. PubMed ID: 15699258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Abbott JD; Vlachos HA; Selzer F; Sharaf BL; Holper E; Glaser R; Jacobs AK; Williams DO;
    Am J Cardiol; 2007 Mar; 99(5):626-31. PubMed ID: 17317361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
    Zhang Z; Weintraub WS; Mahoney EM; Spertus JA; Booth J; Nugara F; Stables RH; Vaccarino V
    Am J Cardiol; 2004 Feb; 93(4):404-9. PubMed ID: 14969611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era.
    Denollet J; Pedersen SS; Ong AT; Erdman RA; Serruys PW; van Domburg RT
    Eur Heart J; 2006 Jan; 27(2):171-7. PubMed ID: 16246826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
    Zhang Z; Mahoney EM; Stables RH; Booth J; Nugara F; Spertus JA; Weintraub WS
    Circulation; 2003 Oct; 108(14):1694-700. PubMed ID: 12975252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age on the outcomes of women following percutaneous coronary intervention in the bare-metal stent era.
    Rathore S; Rhys J; Buchalter MB; Gerning NO; Groves PH; Penny W
    J Interv Cardiol; 2006 Jun; 19(3):245-9. PubMed ID: 16724967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time.
    Champney KP; Veledar E; Klein M; Samady H; Anderson D; Parashar S; Wenger N; Vaccarino V
    Am Heart J; 2007 Jun; 153(6):970-8. PubMed ID: 17540197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.